GCS Home Forum General Discussions & Questions IBM Watson Genomics Tumor Testing

This topic contains 5 replies, has 3 voices, and was last updated by  Cindy Rottkamp 1 month, 2 weeks ago.

  • Author
    Posts
  • #3949

    Cindy Rottkamp
    Participant

    This looks like a great resource, thanks for sharing this information. Do you know how it compares to Foundation One? I am having surgery in a matter of days and I discussed having my tumor tissue analyzed for chemo sensitivity. Is this the same thing? My surgeon said he could send my sample to Foundation One. It appears that the IBM Watson Genomics test is different having to do with mutations. I would like to try both. Anyone have any experience with this?

  • #3945

    Stephanie
    Member
  • #3944

    Stephanie
    Member

    Attached is a PDF of the Quest Diagnostics Brochure. Not sure if it can be viewed on the discussion board but thought I would try.

    Stephanie

  • #3943

    Diane Redington
    Keymaster

    This is so interesting. I am going to follow up and learn more. Sounds groundbreaking!

    Thank you for sharing.

    Diane

  • #3942

    Stephanie
    Member

    Hello Everyone,

    Has anyone considered or had experience in using the testing offered by Quest Diagnostics for treatment plan(s) and comparison of second opinions?

    http://www.questdiagnostics.com/home/patients/tests-a-z/ibm-watson-genomics

    Additional information from brochure in link

    What is Watson Genomics from Quest Diagnostics? Watson Genomics is ground-breaking cancer diagnostics that combines: Quest’s state-of-the-art tumor analysis, IBM Watson’s cognitive computing, and Memorial Sloan Kettering Cancer Center’s expertise, with Research support from The Broad Institute of MIT and Harvard Which patients may benefit from this test? Watson Genomics from Quest Diagnostics is for cancer patients with a solid tumor, and may especially benefit patients with: Certain rare tumor types, Tumors of unknown primary origin, Metastatic or locally advanced cancer, Tumors with no actionable mutations found through guideline-driven testing

    How the test works 1. Quest Diagnostics analyzes the genetic mutations of your patient’s tumor biopsy. 2. IBM Watson compares the mutations against leading science and therapies. 3. Quest medical experts review, validate, and report the results to you with insight into personalized, targeted treatment options and clinical trials that may be appropriate. 4. You and your patient develop a targeted treatment plan that is tailored to him or her.

    Thank you, Stephanie and Karin

  • #3940

    Cindy Rottkamp
    Participant

    IBM Watson Genomics Tumor Testing

You must be logged in to reply to this topic.

GCS FORUM

The GCS community is here for you. Our forum offers support, latest news, education, connections and a safe place to ask your questions.

REGISTER

In order to participate in discussions, or get notified of updates registration is required. Register Here

EXISTING USERS

Use your existing credentials to log in to our new Forum. Login Here or Reset Your Password

SEARCH FORUMS


  • MOST LIKED CONTENT